Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4203197
Max Phase: Preclinical
Molecular Formula: C22H17F2N3O4
Molecular Weight: 425.39
Molecule Type: Small molecule
Associated Items:
ID: ALA4203197
Max Phase: Preclinical
Molecular Formula: C22H17F2N3O4
Molecular Weight: 425.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(-c2nc3cc(NC(=O)[C@H](C)Oc4cccc(F)c4F)ccc3o2)cn1
Standard InChI: InChI=1S/C22H17F2N3O4/c1-12(30-18-5-3-4-15(23)20(18)24)21(28)26-14-7-8-17-16(10-14)27-22(31-17)13-6-9-19(29-2)25-11-13/h3-12H,1-2H3,(H,26,28)/t12-/m0/s1
Standard InChI Key: DYWDDZVJIZPXJJ-LBPRGKRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 425.39 | Molecular Weight (Monoisotopic): 425.1187 | AlogP: 4.58 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.48 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.37 | CX Basic pKa: 2.47 | CX LogP: 4.17 | CX LogD: 4.17 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.49 | Np Likeness Score: -2.12 |
1. Chacko S, Boshoff HIM, Singh V, Ferraris DM, Gollapalli DR, Zhang M, Lawson AP, Pepi MJ, Joachimiak A, Rizzi M, Mizrahi V, Cuny GD, Hedstrom L.. (2018) Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents., 61 (11): [PMID:29746130] [10.1021/acs.jmedchem.7b01839] |
Source(1):